CI Investments Inc
MYOK

CI Investments Inc’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

CI Investments Inc’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,718
Closed -$263K – 984
2020
Q2 		$263K Buy
+2,718
New +$227K ﹤0.01% 507

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

CI Investments Inc's MYOK Position: Q3 2020 in Review

CI Investments Inc sold out of MyoKardia, Inc. Common Stock (MYOK) in Q3 2020, closing a stake of 2,718 shares — an estimated $263K sold.

CI Investments Inc first reported a position in MYOK in Q2 2020 and held it in 1 quarter. The position peaked at $263K in Q2 2020. 237 funds tracked by Wall St. Rank hold MYOK as of Q3 2020.

  • CI Investments Inc reported no remaining MyoKardia, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • CI Investments Inc sold 2,718 MyoKardia, Inc. Common Stock shares in Q3 2020, an estimated $263K.
  • CI Investments Inc first reported a position in MyoKardia, Inc. Common Stock in Q2 2020 and held it in 1 quarter.
  • CI Investments Inc's MyoKardia, Inc. Common Stock position peaked at $263K in Q2 2020.
  • 237 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q3 2020.

Based on CI Investments Inc's 13F filing for Q3 2020, filed 9 Nov 2020.